Molecular diagnostics of bladder cancer.

Molecular diagnostics of bladder cancer. - URICA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30884

Enrollment

Registered

2007-09-26

Start date

2007-10-19

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer urothelial carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with bladder cancer

Exclusion criteria

Exclusion criteria: --

Design outcomes

Primary

Measure	Time frame
The results of either no mutation or a mutation in FGFR3. There are 11 mutations known in FGFR3, which are analyzed simultaneously.	—

Secondary

Measure	Time frame
n.v.t.	—

Countries

Netherlands

Outcome results